Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT

Background: Very late-onset (aged ≥ 60 years) schizophrenia-like psychosis (VLOSLP) occurs frequently but no placebo-controlled, randomised trials have assessed the efficacy or risks of antipsychotic treatment. Most patients are not prescribed treatment. Objectives: The study investigated whether or...

Full description

Bibliographic Details
Main Authors: Robert Howard, Elizabeth Cort, Rosie Bradley, Emma Harper, Linda Kelly, Peter Bentham, Craig Ritchie, Suzanne Reeves, Waleed Fawzi, Gill Livingston, Andrew Sommerlad, Sabu Oomman, Ejaz Nazir, Ramin Nilforooshan, Robert Barber, Chris Fox, Ajay Macharouthu, Pranathi Ramachandra, Vivek Pattan, John Sykes, Valerie Curran, Cornelius Katona, Tom Dening, Martin Knapp, Renee Romeo, Richard Gray
Format: Article
Language:English
Published: NIHR Journals Library 2018-11-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta22670

Internet

https://doi.org/10.3310/hta22670

Similar Items